Page 21 - Lipids News Today

Data from four tirzepatide pivotal trials in people with type 2 diabetes showed ≥15% weight loss in 25% of those on tirzepatide, with seven factors significantly linked with greater weight loss.

Ordering inappropriate cardiac imaging can set off a cascade of unnecessary tests, referrals, and treatment.

An investigational dual PPAR agonist modifies Alzheimers pathology and shows cognitive benefit in adults with mild-to-moderate disease and high plasma pTau-217 ratio, early data show.

Consumption of food-derived oligopeptides has been linked with an increased rate of triglyceride breakdown, enhanced the uptake of non-esterified fatty acids, and the promotion of fat oxidation, both during periods of inactivity and exercise among cyclists.

Hypertension, obesity, diabetes, and other common risk factors for dementia pose an even greater risk to South Asian and Black individuals compared to White persons.

Real-world primary care data indicate that use of antipsychotics and antibiotics, among other meds, can significantly increase the risk of sudden cardiac arrest among people with type 2 diabetes.

Evidence showing the SARS-CoV-2 virus directly infects coronary atherosclerotic plaques, causing a persistent inflammatory response, may lead to new approaches for managing patients after infection.

Men with the most severe erectile dysfunction saw the greatest benefit from working out.

Researchers investigate if oat polar lipid compounds improve glucose tolerance, gut hormonal responses, and triglyceridemia.

Results from myocardial perfusion imaging of 2730 people with diabetes and no known coronary disease show impaired myocardial blood flow reserve predicts mortality regardless of ischemia symptoms.